Northwestern Mutual Wealth Management CO Celldex Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $30 - $38	1 New	1 $0
Q1 2022 May 09, 2022	SELL	$27.64 - $39.32 $2,764 - $3,932	-100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $376 - $727	-13 Reduced 11.5%	100 $5,000
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $269 - $459	13 Added 13.0%	113 $4,000
Q1 2020 May 08, 2020	BUY	$1.55 - $3.07 $155 - $307	100 New	100 $0
Q2 2019 Aug 12, 2019	SELL	$2.43 - $5.09 $272 - $570	-112 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$3.45 - $10.35 $386 - $1,159	112 New	112 $1,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.